3,452 research outputs found
Is the incidence of dementia declining?
Action on preventative health could lower the risk of dementia for future generations, argues this report.
Executive summary
The world-wide projections of the prevalence of dementia in the coming decades have been a source of great concern to health systems and societies around the world. The World Alzheimer Report 2010 estimated that there were 36 million people with dementia in 2010, with an expected doubling every 20 years to nearly 115 million in 2050. These sobering figures are based on assumptions that the age-adjusted prevalence of dementia would remain constant and the population would continue to age at the current rate.
The assumption that the incidence of dementia will remain stable is now being put into question. There is emerging evidence to suggest that the incidence of dementia in older individuals may be declining. It appears that this change may be recent and has possibly occurred only in the last one to two decades. It may also be restricted so far to high income countries, although data from low and middle income countries are lacking.
The reasons for this change are not understood, but education, more stimulating environments and better control of vascular risk factors may have contributed. The data are still preliminary and more studies are needed to establish the extent of this change and understand its causes. It should be noted that the decline is not large enough to offset the increase in prevalence of dementia due to the ageing of the population and therefore investment and efforts to develop better treatments and care for people with dementia need to continue.
The fact that dementia rates are malleable is an encouraging finding but the reduction cannot be taken for granted as gains in population health can easily be lost if societies do not remain vigilant and continually proactive. These preliminary findings provide a strong argument for large scale Government investment in dementia-prevention strategies, which should start from early life
Sachdev–Ye–Kitaev model as Liouville quantum mechanics
AbstractWe show that the proper inclusion of soft reparameterization modes in the Sachdev–Ye–Kitaev model of N randomly interacting Majorana fermions reduces its long-time behavior to that of Liouville quantum mechanics. As a result, all zero temperature correlation functions decay with the universal exponent ∝τ−3/2 for times larger than the inverse single particle level spacing τ≫NlnN. In the particular case of the single particle Green function this behavior is manifestation of the zero-bias anomaly, or scaling in energy as ϵ1/2. We also present exact diagonalization study supporting our conclusions
Spin liquid to spin glass crossover in the random quantum Heisenberg magnet
We study quantum SU() spins with all-to-all and random Heisenberg exchange interactions of root-mean-square strength . The model has a spin liquid ground state with the spinons obeying the equations of the Sachdev-Ye-Kitaev (SYK) model. Numerical studies of the SU(2) model with spins show spin glass order in the ground state, but also display SYK spin liquid behavior in the intermediate frequency spin spectrum. We employ a expansion to describe the crossover from fractionalized fermionic spinons to a confining spin glass state with weak spin glass order . The SYK spin liquid behavior persists down to a frequency , and for \omega < \omega_\ast, the spectral density is linear in , thus quenching the extensive zero temperature entropy of the spin liquid. The linear spectrum is qualitatively similar to that obtained earlier using bosonic spinons for large . We argue that the extensive SYK spin liquid entropy is transformed as to an extensive complexity of the spin glass state
Arterial stiffness, the brain and cognition: A systematic review
Abstract not availableJoel Singer, Julian N. Trollor, Bernhard T. Baune, Perminder S. Sachdev, Evelyn Smit
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies
Neutralizing antibodies (nAbs) that target the SARS-CoV-2 spike protein have received emergency use approval for treatment of COVID-19. However, with the emergence of variants of concern, there is a need for new treatment options. We report a format that enables modular assembly of bi-paratopic tetravalent nAbs with antigen-binding sites from two distinct nAbs. The tetravalent nAb purifies in high yield and exhibits biophysical characteristics that are comparable to those of clinically used therapeutic antibodies. The tetravalent nAb binds to the spike protein trimer at least 100-fold more tightly than bivalent IgGs (apparent K(D) < 1 pM) and neutralizes a broad array of SARS-CoV-2 pseudoviruses, chimeric viruses, and authentic viral variants with high potency. Together, these results establish the tetravalent diabody-Fc-Fab as a robust, modular platform for rapid production of drug-grade nAbs with potencies and breadth of coverage that greatly exceed those of conventional bivalent IgGs
Nodal Quasiparticles and the Onset of Spin-Density-Wave-Order in Cuprate Superconductors
We present a theory for the onset of spin-density-wave order in the superconducting ground state of the cuprates. We compute the scaling dimensions of allowed perturbations of a “relativistic” fixed point with O(4) O(3) symmetry, including those associated with the fermionic nodal Bogoliubov quasiparticles. Analyses of up to six loops show that all perturbations with square lattice symmetry are likely irrelevant. We demonstrate that the fermion spectral functions are primarily damped by the coupling to fluctuations of a composite field with Ising nematic order. A number of other experimental implications are also discussed.PhysicsAuthor's Origina
Non-pharmacological interventions in secondary schizophrenia
Schizophrenia may not be a single disease, but the result of a diverse set of related conditions. Modern neuroscience is beginning to reveal some of the genetic and environmental underpinnings of schizophrenia; however, an approach less well travelled is to examine the medical disorders that produce symptoms resembling schizophrenia. This book is the first major attempt to bring together the diseases that produce what has been termed 'secondary schizophrenia'. International experts from diverse backgrounds ask the questions: does this medical disorder, or drug, or condition cause psychosis? If yes, does it resemble schizophrenia? What mechanisms form the basis of this relationship? What implications does this understanding have for aetiology and treatment? The answers are a feast for clinicians and researchers of psychosis and schizophrenia. They mark the next step in trying to meet the most important challenge to modern neuroscience – understanding and conquering this most mysterious of human diseases
Genetic Engineering for the Poor: Golden Rice and Public Health in India
Vitamin A deficiency (VAD) affects millions of people, causing serious health problems. Golden Rice (GR), which has been genetically engineered to produce β-carotene, is being proposed as a remedy. While this new technology has aroused controversial debates, its actual impact remains unclear. We develop a methodology for ex ante evaluation, taking into account health and nutrition details, as well as socioeconomic and policy factors. The framework is used for empirical analyses in India. Given broad public support, GR could more than halve the disease burden of VAD. Juxtaposing health benefits and overall costs suggests that GR could be very cost-effective
- …
